Kalbitor Approved for Hereditary Angiodema
HealthDay - Thu Dec 3, 12:02 pm ETTHURSDAY, Dec. 3 (HealthDay News) -- Kalbitor (ecallantide) has been approved by the U.S. Food and Drug Administration to treat dangerous flares of sudden fluid buildup in people with hereditary angiodema (HAE), the agency said.